ICMR Completes 100 Technology Transfer Deals in Under Two Years

ICMR Completes 100 Technology Transfer Deals in Under Two Years

The Indian Council of Medical Research (ICMR) has strengthened its efforts to bring indigenous healthcare innovations to the market, completing 100 technology transfer agreements in less than two years. The achievement reflects the growing momentum in translating scientific research into practical healthcare solutions through partnerships with industry.

The milestone was highlighted at the 3rd Department of Health Research (DHR)-ICMR Health Research Excellence Summit, held on November 16 and 17, 2026, at Bharat Mandapam, New Delhi. The event also marked 115 years of ICMR’s contribution to biomedical and health research.

The two-day gathering brought together more than 600 scientists, researchers, innovators, policymakers, administrators and representatives from academic and government institutions. It provided a platform to recognise research achievements, showcase innovations and encourage collaboration across the healthcare research ecosystem.

During the technology transfer ceremony, 20 licensing agreements involving eight technologies were signed with nine Indian companies. This brought the total number of successful technology transfer deals under ICMR’s Medical Innovations Patent Mitra initiative to 100. Launched by Union Health Minister J P Nadda in March 2025, the initiative aims to facilitate the commercialisation and wider application of research-based innovations.

The summit featured an innovation exhibition showcasing 17 technologies developed by ICMR institutes and extramural partner institutions. Another session highlighted 10 technologies and eight patents, demonstrating the breadth of indigenous research and innovation.

Three new initiatives were introduced to strengthen research translation and public health preparedness. DHR’s Research to Action Vertical will focus on converting research findings into actionable inputs for policies and healthcare programmes. The Syndromic Surveillance initiative under the DHR Virus Research and Diagnostic Laboratories (VRDL) Scheme will establish an outbreak-monitoring and early-warning network across 70 VRDLs and Infectious Disease Research & Diagnostic Laboratories (IRDLs). The Dr M K Bhan Young Medical Faculty PhD Portal was launched as a centralised digital platform to provide information to prospective applicants.

ICMR also released its Antimicrobial Resistance (AMR) Annual Report and Standard Operating Procedures, consolidating national evidence and laboratory guidelines on antimicrobial resistance. The ICMR Compendium, featuring 25 accounts of research translated into tangible outcomes, was released as well.

Research excellence was showcased through presentations of shortlisted scientific publications, technologies and patents. Discussions on research administration and finance explored ways to improve grant management, procurement and financial procedures. The event also celebrated 50 years of the ICMR-National Institute of Malaria Research and its contribution to malaria research.

Researchers and institutions were honoured across nine categories under the Research, Innovation and Institutional Excellence Recognition for achievements in publications, patents, technologies and institutional performance. The ICMR Research Management Excellence Recognition acknowledged the contributions of research reviewers, the Indian Journal of Medical Research, scientific divisions, support units and administration and finance teams.

The summit also recognised 100 school students selected through ICMR’s SHINE National Competition for their scientific thinking and public health contributions. SHINE (Science and Health Innovation for the NextGen Explorers) is designed for students in Grades 9 to 12 across government, government-aided and private schools, encouraging scientific curiosity and interest in biomedical and health research careers.

The summit concluded with a renewed emphasis on strengthening partnerships between research institutions, industry and policymakers to accelerate the development and adoption of healthcare innovations.

With 100 technology transfer agreements achieved in under two years, ICMR’s initiative underscores the potential of Indian biomedical research to move beyond laboratories and contribute to real-world healthcare solutions, supporting the country’s pursuit of accessible, affordable and quality healthcare.

Leave a Reply

Your email address will not be published. Required fields are marked *